Crop Life Science Limited (**CLSL**) is a prominent Indian agrochemical player established in **2006**. The company has successfully transitioned from a small-scale formulation unit into a vertically integrated manufacturer, distributor, and exporter of a wide range of crop protection and plant health solutions. Listed on the **NSE Emerge Platform** since **August 30, 2023**, CLSL operates across the entire agri-value chain, from R&D and manufacturing to branded retail and international trade. --- ### Core Business Segments and Revenue Streams CLSL operates under two primary business segments as defined by **Ind AS 108**. While the company is primarily an agrochemical manufacturer, it also engages in strategic trading to optimize market reach. | Segment | Description | Revenue (FY 2023-24) | Revenue (H1 FY 2024-25) | | :--- | :--- | :--- | :--- | | **Agro Chemicals** | Manufacturing and dealing in pesticides, insecticides, herbicides, fungicides, and fertilizers. | **₹16,512.84 Lacs** | **₹11,926.50 Lacs** | | **Agro Trade** | Trading of various Agro Products (Secondary segment). | **₹3,558.78 Lacs** | **₹100.75 Lacs** | In addition to its branded portfolio, the company generates revenue through **third-party job work**, manufacturing pesticides and micro-fertilizers for other industry players. --- ### Manufacturing Infrastructure and Technical Capabilities The company’s operational backbone is centered in the industrial heart of Gujarat, supported by robust regulatory approvals and quality certifications. * **Strategic Location:** The primary manufacturing unit is situated in the **GIDC Industrial area at Ankleshwar, Gujarat**, spanning **5,831.10 Square Meters** on a **99-year lease**. * **Regulatory Approvals:** CLSL holds a massive portfolio of **302 technical formulation approvals** from the Directorate of Agriculture, Gujarat. This includes **44 formulations** specifically approved for the export market. * **Quality and R&D:** The facility is **ISO 9001:2015** (Quality Management) and **ISO 14001:2015** (Environmental Management) certified. In **2021-22**, the company inaugurated a dedicated **Biological Research and Development Laboratory** at Ankleshwar to focus on eco-friendly solutions. * **Asset Optimization:** In **September 2025**, the company executed a strategic asset sale of a portion of its **GIDC industrial land** for **₹344.99 Lacs**, which included the transfer of an outstanding loan of **₹216.77 Lacs** to the purchaser, improving the balance sheet. --- ### Product Portfolio and Recent Market Launches Since starting with only **25** products in **2007**, CLSL has expanded to over **100** branded products. The portfolio covers insecticides, fungicides, herbicides, Plant Growth Regulators (PGR), and bio-fertilizers. **Key Product Launches (Q1 2024-25):** The company aggressively expanded its domestic portfolio in mid-2024 with several high-impact technical compositions: | Product Name | Category | Technical Composition | Launch Date | | :--- | :--- | :--- | :--- | | **FRONTONIL** | Insecticide | Fipronil **0.6% W/W GR** | June 05, 2024 | | **CROPLOD** | Herbicide | Tembotrion **34.4% SC** | June 05, 2024 | | **POWERKIN** | PGR | Paclobutrazol **23% SC** | May 31, 2024 | | **FERAMITOZ** | PGR | Alpha Nepthyl acetic acid **4.5% SL** | May 31, 2024 | | **SAMYOJAN** | Insecticide | Bispyribac Sodium **10% SC** | May 24, 2024 | | **BIO-PRAHAR** | Insecticide | Abamectin **1.9% EC** | May 22, 2024 | | **BUPLON 32** | Insecticide | Pendimethalin **30%** + Imazethapyr **2% EC** | May 22, 2024 | --- ### Distribution Network and Market Expansion Strategy CLSL employs a multi-pronged strategy to deepen market penetration both domestically and globally. * **Domestic Reach:** The company maintains an extensive network of approximately **2,500 channel distributors** and wholesalers. It has a strong presence in **Gujarat, Maharashtra, Uttar Pradesh, Madhya Pradesh, Bihar, West Bengal, and Chhattisgarh**. * **Supply Chain Infrastructure:** Strategic **godowns and depots** are maintained across key states to ensure PAN-India delivery. * **International Footprint:** CLSL has seen exponential growth in exports, reaching markets including **China, Egypt, Saudi Arabia, Ethiopia, Gabon, Indonesia, Morocco, Nepal, Bangladesh, Vietnam, Sudan, and the UAE**. * **Farmer Engagement:** The company operates a dedicated **call center in Vadodara** to provide technical guidance to farmers, complemented by field demonstrations and farmer training programs. --- ### Financial Structure and Capital Management Following its IPO, which raised **₹26.73 Crore**, the company has focused on optimizing its working capital and debt profile. **Debt and Interest Sensitivity:** The company’s borrowing has shifted toward variable-rate instruments, requiring active management of interest rate risks. | Particulars (INR in Lacs) | As at March 31, 2025 | As at March 31, 2024 | | :--- | :--- | :--- | | **Fixed Rate Borrowings** | **239.11** | **283.40** | | **Variable Rate Borrowings** | **3,820.18** | **2,692.88** | | **Total Borrowings** | **4,059.29** | **2,976.28** | * **Liquidity:** As of March 31, 2025, unutilized bank credit limits stood at **₹2.28 Crores**. * **Foreign Exchange Exposure:** Export sales grew from **₹186.49 Lacs** in FY23 to **₹2,580.64 Lacs** in FY24, significantly increasing exposure to **USD** and **EURO** fluctuations. Trade receivables in **USD** reached **₹525.89 Lacs** by March 2025. --- ### Corporate Governance and Management * **Leadership:** Led by **Rajeshkumar Vrajlal Lunagariya** (Managing Director). **Ashvinkumar Ravji Lunagaria** was appointed as **CFO** effective **April 1, 2025**. * **Board Oversight:** The board was strengthened with the appointment of **Ms. Sheetalben Rachit Shah** as an Additional Independent Director in **April 2026** for a **5-year term**. * **Subsidiaries:** **Hetban Spechem Limited** became a material subsidiary on **March 27, 2024**, further expanding the group's manufacturing capabilities. * **Operational Centralization:** The registered office was shifted from Ahmedabad to **Vadodara** in **September 2024** to improve proximity to promoters and centralize management. --- ### Risk Profile and Mitigation Framework CLSL operates in a high-risk, high-reward environment characterized by climatic and regulatory volatility. **1. Operational & Environmental Risks:** * **Climatic Dependency:** The business is highly seasonal. For instance, in **FY2025**, an extended monsoon led to lower pest infestations and muted volume growth. * **Market Evolution:** The rise of **Organic Farming** and **Integrated Pest Management (IPM)** presents a long-term threat to traditional chemical demand, which the company is mitigating through its **Biological R&D Lab**. **2. Financial Risks:** * **Interest Rate Risk:** A **50bps increase** in rates would impact **PBT** by **₹19.10 Lacs**. The company uses **Interest Rate Swaps** to hedge risks associated with **External Commercial Borrowings (ECB)**. * **Credit Risk:** Managed via a simplified **Expected Credit Loss (ECL)** model; historical data indicates negligible bad debt provisions. **3. Regulatory & Compliance Risks:** * **Approval Delays:** Agrochemical registrations are lengthy and capital-intensive. * **Compliance History:** The company has previously noted technical non-compliance with **Sections 185 and 186** of the Companies Act regarding related-party advances and experienced a delayed **2023 AGM** due to a lack of quorum. **4. Human Capital Risks:** * **Gratuity Obligations:** The company manages a defined benefit plan with a weighted average duration of **7.38 years**. It faces actuarial risks if salary growth exceeds assumptions or if market discount rates fluctuate.